Spire Wealth Management Has $5.04 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Spire Wealth Management grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 4,094.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 8,473 shares of the biotechnology company’s stock after acquiring an additional 8,271 shares during the quarter. Spire Wealth Management’s holdings in Axon Enterprise were worth $5,036,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Groupama Asset Managment acquired a new position in Axon Enterprise in the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at $120,553,000. International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $652.18 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $49.73 billion, a PE ratio of 168.52, a PEG ratio of 6.54 and a beta of 1.05. The stock’s 50 day moving average price is $619.63 and its 200-day moving average price is $483.68. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67.

Insiders Place Their Bets

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. Insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on AXON. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. JMP Securities boosted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Robert W. Baird boosted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.